دورية أكاديمية

Unraveling Acute and Post-COVID Cytokine Patterns to Anticipate Future Challenges.

التفاصيل البيبلوغرافية
العنوان: Unraveling Acute and Post-COVID Cytokine Patterns to Anticipate Future Challenges.
المؤلفون: Bekbossynova, Makhabbat, Tauekelova, Ainur, Sailybayeva, Aliya, Kozhakhmetov, Samat, Mussabay, Karakoz, Chulenbayeva, Laura, Kossumov, Alibek, Khassenbekova, Zhanagul, Vinogradova, Elizaveta, Kushugulova, Almagul
المصدر: Journal of Clinical Medicine; Aug2023, Vol. 12 Issue 16, p5224, 19p
مصطلحات موضوعية: COVID-19 pandemic, CORONAVIRUS diseases, COVID-19, TYPE 2 diabetes, CYTOKINES, GLUCOSE intolerance
مستخلص: The aims of this study were to analyze cytokine profiles in patients with COVID-19, gain insights into the immune response during acute infection, identify cytokines associated with disease severity and post-COVID complications, and explore potential biomarkers for prognosis and therapeutic targets. Using a multiplex analysis, we studied the cytokine pattern in 294 acute COVID-19 and post-COVID patients with varying severities of infection. Our findings revealed that disease severity was associated with elevated levels of IL-15, IL-8, and fractalkine. Severe/extremely severe forms in comparison with mild/moderate disease were associated with MCP-1, IFNa2, IL-7, IL-15, EGF, IP-10, IL-8, Eotaxin, FGF-2, GROa, sCD40L, and IL-10. The key cytokines of post-COVID are FGF-2, VEGF-A, EGF, IL-12(p70), IL-13, and IL-6. By the sixth month after recovering from a coronavirus infection, regardless of disease severity, some patients may develop complications such as arterial hypertension, type 2 diabetes mellitus, glucose intolerance, thyrotoxicosis, atherosclerosis, and rapid progression of previously diagnosed conditions. Each complication is characterized by distinct cytokine profiles. Importantly, these complications can also be predicted during the acute phase of the coronavirus infection. Understanding cytokine patterns can aid in predicting disease progression, identifying high-risk patients, and developing targeted interventions to improve the outcomes of COVID-19. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Clinical Medicine is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:20770383
DOI:10.3390/jcm12165224